KLOW 80 mg Blend

Healing & recovery Research compound (not approved for human use)

Tissue-repair and anti-inflammatory blend (four peptides) · also known as KLOW peptide blend, GHK-Cu + BPC-157 + TB-500 + KPV

For reference only — not medical advice. Figures are commonly reported values compiled from published sources and may be wrong or out of date. Many compounds listed are not approved for human use. Talk to a licensed clinician before using any compound.

KLOW adds 10 mg of KPV to the three-peptide GLOW composition, keeping the same 5:1:1 ratio for GHK-Cu, BPC-157 and TB-500. The reported chart steps all four components up together over eight weeks and then returns to the mid step.

Commonly reported dosing (80 mg vial)

Reconstituted with 3 mL → 26.667 mg/mL.

Phase	Dose	Volume	U-100 units
Starting Weeks 1-2, total blend (GHK-Cu 1.25 mg; BPC-157, TB-500 and KPV 0.25 mg apiece)	2 mg	0.075 mL	7.5
Standard Weeks 3-4 and weeks 9-12, total blend	4 mg	0.15 mL	15
Higher Weeks 5-8, total blend	6 mg	0.225 mL	22.5

Each 2 mg draw contains 1.25 mg GHK-Cu + 250 mcg BPC-157 + 250 mcg TB-500 + 250 mcg KPV.

Frequency: Once daily, subcutaneous · Half-life: Mixed (see individual peptides)

Open in calculator

Commonly reported reconstitution steps

Vials are usually brought to room temperature (about 15-20 minutes) first.
3 mL of bacteriostatic water is added slowly down the inside wall of the 80 mg vial.
The vial is swirled gently until clear, not shaken.
This gives 26.67 mg/mL. Mixed vials are typically labeled with the date and refrigerated.

Storage

Before mixing: Sealed vials are commonly stored refrigerated (2-8 °C) and protected from light, or frozen for long-term storage.

After mixing: Reconstituted solution is commonly kept refrigerated (2-8 °C), protected from light, and not frozen.

Commonly used within 28 days of mixing.

How it works

GHK-Cu is tied to collagen synthesis and tissue remodeling, BPC-157 to angiogenesis, TB-500 to cell migration and actin regulation, and KPV (a fragment of alpha-MSH) to NF-kB-linked anti-inflammatory signaling.

Researched for

Studied per component in wound-healing, connective-tissue and gut-inflammation models.
Investigated as a combined repair-plus-inflammation research protocol.

Notes

No controlled human trial has tested the four-peptide combination; the evidence is per component and mostly preclinical.
Because it is a blend, every syringe marking changes all four amounts together, with GHK-Cu at five times the mass of each of the others.
Reconstituted solution is commonly refrigerated.